Phlebotomist
GRIFOLS, S.A.
Summary
Our ideal phlebotomist is patient, reliable, and really commits to keep our donors comfortable and happy.
Job description
Phlebotomist – We Train
Our ideal phlebotomist is patient, reliable, and really commits to keep our donors comfortable and happy.
Primary Responsibilities:
- Assist in determining the suitability of donors.
- You establish rapport with donors to ensure overall customer happiness while ensuring donor confidentiality.
- You respond to and assist with handling donor reactions.
- Monitors donor and equipment to ensure health of donors and quality of product.
- Sets up, disconnects, and operates the automated plasmapheresis machines.
- Disconnects and disposes of all contaminated disposable equipment.
Requirements
- Superior customer service standards
- A High School diploma or GED
- Ability to work a flexible schedule
- An interest in making a difference in the world
- Obtains required state licensures or certifications where applicable
Company overview
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines, founded in Barcelona, Spain in 1909. As the European leader and third largest plasma-derived medicine manufacturer worldwide, Grifols specializes in developing, producing, and marketing essential plasma-derived protein therapies for patients suffering from rare, chronic, and life-threatening conditions. The company operates across four main business units: Biopharma (plasma-derived medicines), Diagnostic (transfusion medicine and clinical diagnostics), Bio Supplies (biological materials for research), and Healthcare Solutions for Hospitals. With over 23,800 employees serving more than 110 countries, Grifols maintains 15 industrial facilities across seven countries and operates approximately 400 plasma donation centers globally. The company focuses on therapeutic areas including immunology, infectious diseases, pulmonology, hematology, hepatology, intensive care, and neurology, with more than 1,200 researchers working across 12 R&D centers worldwide. Grifols is publicly traded on both the Madrid Stock Exchange (GRF) and NASDAQ (GRFS), generating approximately €7.2 billion in annual revenue.